Tingyu Qu


University of Illinois at Chicago
Department of Psychiatry 
1601 W. Taylor Street, (M/C 912)
Chicago, IL 60612

Office Phone: (312) 355-1786
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


Fox L, Shen J, Ma K, Liu Q, Shi G, Pappas GD, Qu T*, Cheng J*, Membrane properties of neuron-like cells generated from adult human bone marrow-derived mesenchymal stem cells, Stem Cells Dev. 2010

Shi, GB., Ma, K., Pappas, GD., and Qu, T*., Phenotypic characteristics of hybrid cells produced by cell fusion of porcine adrenal chromaffin cells with human mesenchymal stem cells: A preliminary study, Neurol Res. 2008, 30(3):217-22

Qu, T., Dong, X., Sugaya, I., Vaghani, A., Pulido, JS., and Sugaya, K., Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells, Restorative neurology and Neuroscience, 22:6 (2004) 459-468

Kim, M., Qu, T., Kriho, V., Lacor, P., Smalheiser, N., Pappas, GD., Guidotti, A., Costa, E. and Sugaya, K., Reelin function in neural stem cell biology, Proc Natl Acad Sci USA , 99 (2002) 4020-4025

Qu, T., Brannen, C.L., Kim, M., and Sugaya, K., Human neural stem cells improve cognitive function of aged brain, NeuroReport, 12 (2001) 1121-1132

Qu, T., Manev, R. and Manev, H., 5-Lipoxygenase (5-LOX) promoter polymorphism in patients with early and late onset Alzheimer’s disease, The Journal of Neuropsychiatry and Clinical Neurosciences 13 (2001) 304-305

Tingyu Qu, MD, PhD

Research Assistant Professor at Dept of Psychiatry
Adjunct Assistant Professor at Dept of Anatomy and Cell Biology

Dr. Qu’s research is focused on the therapeutic potential of human stem cells (hSCs), including human fetal and adult stem cells in Alzheimer’s (AD), Parkinson’s (PD), stroke, and spinal cord injury. The ultimate goal is to develop therapeutic strategies for these currently incurable CNS diseases by using stem cell-based therapies. Dr. Qu is also an active researcher in persistent and intractable chronic pain treatment by reprogrammed stem cells. He is a Visiting Scientist and Consultant for stem cell reprogramming at the Cleveland Clinic (2009), and Grant Reviewer of Alzheimer’s Association (2003-2009).

Stem cell reprogramming; therapeutic potential of stem cells in neurological and neurodegenerative diseases; stem cells in pain management

Neuroreplacement therapy for PD: the goal is to generate functional dopaminergic cells from human fetal neural stem cells and adult stem cells for neuroreplacement therapy in PD.

You are here: Home